Athrix (eBook)

The Last Dragon's Bible

Hossein Tolooee (Autor)

eBook Download: EPUB

2025 | 1. Auflage
396 Seiten
Publishdrive (Verlag)
978-0-00-099806-4 (ISBN)

Infos

 ATHRIX: THE LAST DRAGON'S BIBLE

 The Ultimate Thriller That Will Change How You See Reality Forever

What if the most powerful tech billionaires weren't human?

What if consciousness itself could be hacked, transferred, and weaponized?

What if humanity's greatest evolutionary leap was hidden in plain sight?

Textauszug

Chapter One: The Berlin Awakening

The fluorescent lights of the Oracle Corporation's Berlin genetic research facility hummed with the mechanical precision that Dr. Elena Vasquez had grown to associate with corporate efficiency. At three-seventeen in the morning, the sterile corridors echoed only with the distant whir of centrifuges and the occasional beep of monitoring equipment. Elena preferred these late-night hours when the facility belonged to serious researchers rather than corporate executives with their endless meetings about market penetration and intellectual property portfolios.She adjusted her protective eyewear and returned her attention to the blood sample that had been puzzling her for the past forty-eight hours. Patient designation A-7793, real name Athrix Draconis according to the immigration documentation, had submitted to routine genetic screening as part of Oracle's European Union employee onboarding process. What should have been a standard compatibility assessment for their revolutionary new health monitoring systems had instead yielded results that challenged everything Elena understood about human genetics.

The initial screening had flagged unusual protein structures in the subject's hemoglobin, suggesting possible genetic mutations that might interfere with Oracle's biometric tracking systems. Standard protocol required Elena to conduct secondary analysis using the facility's advanced sequencing equipment, technology that rivaled anything available at major universities. Oracle spared no expense when it came to understanding the biological foundations of their employee base, particularly for positions requiring high-level security clearance.Elena had expected to find minor variations, perhaps some benign polymorphisms that occurred naturally in populations with diverse ethnic backgrounds. Instead, the secondary analysis had revealed protein chains that appeared to incorporate trace amounts of metallic elements in configurations that should have been toxic to human physiology. The subject's cellular mitochondria demonstrated energy production rates nearly forty percent above normal human parameters, while maintaining perfect metabolic balance. Most disturbing of all, the genetic markers suggested evolutionary adaptations that had no precedent in any database Elena could access.

She reached for her secure terminal and began documenting her findings with the methodical precision that had earned her tenure at Oracle despite her relative youth. At thirty-two, Elena represented the new generation of corporate researchers who understood that scientific discovery now occurred within commercial frameworks rather than academic institutions. Oracle's genetic research division offered resources that university laboratories could only dream of, along with compensation packages that made academic careers seem quaint by comparison.The blood sample under her microscope continued to exhibit properties that defied conventional understanding. When exposed to electromagnetic fields, the cellular structures demonstrated organizational patterns that suggested conscious response rather than random molecular movement. The red blood cells maintained structural integrity under conditions that should have caused immediate hemolysis, while white blood cell activity indicated immune system function that operated at superhuman efficiency levels.Elena paused in her documentation to consider the implications of her discoveries. Oracle Corporation had invested billions of dollars in developing biometric monitoring systems that could track individual genetic markers with unprecedented precision. Their technology promised to revolutionize healthcare by providing real-time physiological data that could predict medical conditions before symptoms appeared. The system's effectiveness depended on accurate baseline measurements of normal human genetic variation, which made anomalous results like those from patient A-7793 particularly significant.

She accessed the subject's employment file through Oracle's secure personnel database. Athrix Draconis, twenty-eight years old, held advanced degrees in computational linguistics and applied mathematics from institutions across three European countries. His employment application indicated expertise in ancient language analysis and cryptographic systems, skills that had attracted Oracle's attention for their archaeological data mining projects. The company had recently acquired extensive databases of historical manuscripts and artifacts, requiring specialists who could decode ancient texts for potential technological insights.

The photograph attached to Draconis's personnel file showed a man of indeterminate ethnic origin with sharp features and unusually pale eyes. His educational background suggested exceptional intellectual capability, while his multilingual fluency indicated the kind of cultural adaptability that Oracle valued for international operations. Nothing in his documented history suggested the biological anomalies that Elena had discovered in his genetic profile.

She returned to her microscopic analysis, adjusting the magnification to examine individual cellular structures in greater detail. The mitochondrial DNA revealed sequences that appeared to incorporate genetic material from unknown sources, creating hybrid structures that combined human genetic foundations with elements that had no correlation to any known biological organisms. The implications were staggering. Either Athrix Draconis represented a previously undiscovered human subspecies, or his genetic profile had been altered through technologies that exceeded current scientific capabilities.

Elena's secure terminal chimed softly, indicating an incoming message through Oracle's encrypted communication system. The sender identification showed Director Marcus Kellerman, head of the European genetic research division and Elena's direct supervisor. His message was brief and carried the kind of corporate urgency that typically preceded major personnel decisions.

Dr. Vasquez, please report to Conference Room Alpha-7 immediately. Bring all documentation related to subject A-7793. Priority classification: MAXIMUM SECURITY.

Elena felt a familiar tension in her stomach as she gathered her research files and secured the blood samples in the facility's biohazard storage system. MAXIMUM SECURITY classifications were rare in Oracle's European operations, typically reserved for discoveries with significant commercial or strategic implications. Her research into Athrix Draconis's genetic anomalies had apparently attracted attention from corporate leadership, which could represent either extraordinary career advancement or serious professional complications.She made her way through the facility's security checkpoints, submitting to retinal scans and biometric verification at each level. Oracle's Berlin facility operated under military-grade security protocols, a necessity given the sensitive nature of their genetic research and the valuable intellectual property contained within their databases. The company's technology represented billions of dollars in research investment, making corporate espionage a constant threat that required comprehensive protective measures.

Conference Room Alpha-7 occupied the facility's highest security level, accessible only to personnel with clearance ratings that Elena had achieved only recently. The room itself was a marvel of technological sophistication, equipped with holographic projection systems and electromagnetic shielding that prevented external surveillance. Oracle spared no expense when it came to protecting their most sensitive discussions from potential eavesdropping by competitors or government agencies.Director Kellerman waited inside the conference room along with two individuals whom Elena did not recognize. The director's usual corporate demeanor seemed strained, suggesting that her research had generated complications extending beyond routine scientific curiosity. His companions appeared to represent different organizational cultures, based on their contrasting appearance and body language.

Dr. Vasquez, Director Kellerman began without preliminary pleasantries, "your research into subject A-7793 has attracted attention from our strategic partners. I'd like you to meet Dr. Liara Rahimi from the International Monetary Fund's Special Research Division, and Agent Sarah Chen from European Union Intelligence Coordination.Elena nodded politely while attempting to process the implications of their presence. The International Monetary Fund maintained research divisions that supposedly focused on economic analysis and financial stability, but Elena had heard rumors about special projects involving technological assessment and strategic intelligence gathering. European Union Intelligence Coordination operated even more discreetly, coordinating information between member nations on matters involving international security and emerging technological threats.Dr. Rahimi appeared to be approximately Elena's age, with Middle Eastern features and the kind of composed confidence that suggested extensive experience in complex negotiations. Her clothing was professionally elegant without being ostentatious, and her handshake conveyed both strength and precision. Agent Chen maintained the carefully neutral expression that Elena associated with intelligence professionals, revealing nothing about her reactions to the current situation while clearly assessing everyone present for potential threats or advantages.

Dr. Vasquez, Dr. Rahimi began, her voice carrying a slight accent that Elena could not immediately identify, "your research into the genetic profile of Athrix Draconis has implications that extend well beyond Oracle Corporation's commercial...

Produkt-Details

• Erscheint lt. Verlag: 7.8.2025
• Sprache: englisch
• Themenwelt: Literatur ► Krimi / Thriller / Horror
• ISBN-10: 0-00-099806-0 / 0000998060
• ISBN-13: 978-0-00-099806-4 / 9780000998064